Search Results 931-940 of 11268 for Antifungal Resistance

  1. A Study to Evaluate Baricitinib (LY3009104) to Treat Cutaneous Lichen Planus - Mayo Clinic

    To predict responses through the identification of unique biomarkers of LP at week 0 and utilizing RNA sequencing on responsive and non-responsive tissue at ...

  2. Medical Research & Education - Mayo Clinic News Network

    May 14, 2026. Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image. Research. Mayo Clinic ...

  3. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy And Safety Study Of SHP647 As Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    ... fungal infections such as histoplasmosis or ... resistance are < 5%. Subjects from regions with ... Subjects from regions with higher rates of primary multidrug TB ...

  4. A Study Evaluating The Efficacy And Safety Of Obinutuzumab In Participants With Primary Membranous Nephropathy - Mayo Clinic

    History of resistance (no response) to CNIs or B-cell depleting antibodies. ... Known active infection of any kind, excluding fungal infection of the nail beds.

  5. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image. Research. Mayo Clinic researchers identify ...

  6. A Clinical Study Using MEDI-551 In Adult Subjects With Relapsed Or Refractory Advanced B-Cell Malignancies

    Evidence of significant active infection requiring antimicrobial, antifungal, antiparasitic, or antiviral therapy or for which other supportive care is given ...

  7. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image. Research. Mayo Clinic researchers identify ...

  8. A Study To Evaluate Dabrafenib And Trametinib With Or Without Hydroxychloroquine In Advanced Melanoma - Mayo Clinic

    ... resistance and delay disease progression in treating patients with stage IIIC or IV BRAF V600E/K melanoma. Hydroxychloroquine may cause cell death in tumor ...

  9. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image · Mayo Clinic and Stanford researchers develop ...

  10. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

    Ovarian cancer patients with resistance to at least one platinum-based therapy defined according to GCIG. Disease progression during or within 6 months of ...